; and (2) that includes regulatory and legislative recommendations to address any adverse effects of health care consolidation and private equity’s involvement in health care. (e) Moratorium (1) In general The Secretary of Health and Human Services may prohibit a private equity fund from purchasing voting securities of a covered firm, and may prohibit any merger or acquisition that would result in a private equity fund gaining control of voting securities of a covered firm, until the date on which the Secretary determines that the Task Force has had sufficient time to study and identify whether abuses are taking place in specific health care sectors or by health care entities related to price gauging, understaffing, regulation compliance violations, or such other metrics as the Secretary may determinate appropriate. (2) Definitions In this subsection: (A) Covered firm The term covered firm has the meaning given that term under section 1150C(g) of the Social Security Act. (B) Private equity fund The term private equity fund means— (i) a company or partnership that would be considered an investment company under section 3 of the Investment Company Act of 1940 ( 15 U.S.C. 80a–3 ) but for the application of paragraph (1) or (7) of subsection (c) of such section 3; (ii) a venture capital fund, as defined under section 275.203(l)–1of title 17, Code of Federal Regulations; and (iii) a sovereign wealth fund.